Data on 483 patients with poorly controlled, insulin-naive type 2 diabetes showed those in a structured intervention for self-monitoring of their blood glucose levels attained greater reductions in their level of high-sensitivity C-reactive protein at three, six and 12 months compared with those in the control group. The results appear in Diabetes Care.
Lower C-reactive protein level seen with self-monitoring program
SmartBrief Job Listings for Health Care
|Chief Financial Officer||
B. E. Smith
Attest Health Care Advisors
|Biotechnology/Pharmaceutical Patent Attorney||
Coats and Bennett PLLC
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|